Markets Stocks Economy Crypto Earnings Banking Energy
Home Markets Feature
Markets · Exclusive

Yuan holds near 3-1/2-year high as PBOC signals caution on gains

Yuan holds near 3-1/2-year high as PBOC signals caution on gains
Markets · 2026
Photo · Marcus Devlin for Daily Digest Invest
By Marcus Devlin Equities Correspondent Aug 28, 2026 3 min read

China's yuan barely moved on Friday, holding near its strongest level against the U.S. dollar in three and a half years. The onshore yuan traded around 6.7211 per dollar, as investors kept one eye on the Federal Reserve's Jackson Hole symposium for clues about the path of U.S. interest rates.

The People's Bank of China (PBOC) set its daily guidance rate at 6.7811, a notably weaker level than the market rate. That gap is significant: the guidance rate is the central bank's official reference point, and setting it weaker than where the currency actually trades signals that officials are leaning against further rapid appreciation.

Why the gap matters

The PBOC uses a daily fixing to guide the yuan's trading range. When the fixing is set weaker than the market rate, it's often read as a signal that policymakers want to slow the currency's climb. In this case, the gap suggests the central bank prefers low-volatility moves and only gradual appreciation, rather than a sharp revaluation.

For everyday investors, the yuan's strength is a double-edged sword. A stronger yuan makes Chinese exports more expensive abroad, which can weigh on the earnings of Chinese manufacturers and exporters. On the other hand, it makes imports cheaper and can help temper imported inflation. For global investors, a firmer yuan often supports demand for Chinese assets, as it boosts the local-currency value of foreign investments.

Jackson Hole in focus

Markets were largely in a holding pattern as traders awaited the annual Jackson Hole economic symposium, where Federal Reserve officials often signal policy shifts. The event has taken on added weight this year, with investors looking for hints on when the Fed might taper its bond purchases or raise interest rates. Any signal of tighter U.S. monetary policy could strengthen the dollar and put pressure on the yuan.

Related market moves were muted across Asia, with Asian markets holding steady ahead of the speech. Treasury yields also dipped as traders positioned for the event, and gold edged higher on the same uncertainty.

What it means for investors

For investors with exposure to Chinese assets, the PBOC's stance is a reminder that the central bank is actively managing the currency. While the yuan's strength reflects China's solid economic recovery and robust trade surplus, policymakers are wary of letting it rise too quickly, which could hurt export competitiveness and create financial instability.

The takeaway is that the yuan is unlikely to make dramatic moves in either direction in the near term. The PBOC's preference for gradual, low-volatility appreciation means investors should expect a slow grind higher rather than a sudden jump. That could be supportive for Chinese equities, as a stable currency reduces uncertainty for foreign investors.

However, the bigger driver remains the Fed. If Jackson Hole signals a faster move toward tighter U.S. policy, the dollar could strengthen, and the yuan's rally might stall. Conversely, a dovish tone could give the yuan more room to appreciate, though the PBOC would likely step in to smooth the path.

For now, the yuan's resilience is a sign of China's economic strength, but the central bank's cautious hand suggests it won't let the currency run too far ahead. Investors should watch both the PBOC's daily fixings and any Fed signals for clues about the next leg of the currency's move.

More from this story

Next article · Don't miss

Chip and pharma projects could lift US factory construction above $200B

UBS expects US factory construction to rebound, led by new chip and pharma projects. Manufacturing-related building could top $200 billion by end of next year after a recent slowdown.

Read the story →
Chip and pharma projects could lift US factory construction above $200B